Search research articles
Contact Us
Filters
Showing results (781-790 of 890) with videos related to
Page
of 89
Sort By:
Ebiomedicine
|
March 26, 2025
Cerebrospinal fluid metabolomics in autistic regression reveals dysregulation of sphingolipids and decreased β-hydroxybutyrate
Jingya Yan, Velda X Han, Hannah F Jones, et al.
Emerging Infectious Diseases
|
February 19, 2026
Life-Threatening SARS-CoV-2-Associated Encephalopathy and Multiorgan Failure in Children, Asia and Oceania, 2022-2024
Mariko Kasai, Hiroshi Sakuma, Motomasa Suzuki, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
March 9, 2022
Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children: An International Perspective
Thomas Rossor, E Ann Yeh, Yasmin Khakoo, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
January 8, 2026
Cumulative environmental exposures adversely impact social behaviour and are associated with dysregulation of genes and proteins involved in epigenetic, ribosomal, and immune regulation in male mice
Morgan C Bucknor, Brooke A Keating, Velda X Han, et al.
Cell Reports. Medicine
|
January 20, 2023
Humoral signatures of MOG-antibody-associated disease track with age and disease activity
Marianna Spatola, Omar Chuquisana, Wonyeong Jung, et al.
Human Mutation
|
April 23, 2014
TCIRG1-associated congenital neutropenia
Vahagn Makaryan, Elisabeth A Rosenthal, Audrey Anna Bolyard, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
November 19, 2025
Butyrate modifies epigenetic and immune pathways in peripheral mononuclear cells from children with neurodevelopmental disorders associated with chromatin dysregulation
Jessica P Hayes, Velda X Han, Brooke A Keating, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 17, 2017
Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination
Sudarshini Ramanathan, Shekeeb Mohammad, Esther Tantsis, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
October 24, 2014
Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton
Russell C Dale, Esther M Tantsis, Vera Merheb, et al.
Clinical & Translational Immunology
|
January 11, 2021
Pro-inflammatory dopamine-2 receptor-specific T cells in paediatric movement and psychiatric disorders
Deepti Pilli, Alicia Zou, Ruebena Dawes, et al.
Page
of 89
Search research articles
Search
Showing results (781-790 of 890) with videos related to
Sort By:
Page
of 89
Ebiomedicine
|
March 26, 2025
Cerebrospinal fluid metabolomics in autistic regression reveals dysregulation of sphingolipids and decreased β-hydroxybutyrate
Jingya Yan, Velda X Han, Hannah F Jones, et al.
Emerging Infectious Diseases
|
February 19, 2026
Life-Threatening SARS-CoV-2-Associated Encephalopathy and Multiorgan Failure in Children, Asia and Oceania, 2022-2024
Mariko Kasai, Hiroshi Sakuma, Motomasa Suzuki, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
March 9, 2022
Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children: An International Perspective
Thomas Rossor, E Ann Yeh, Yasmin Khakoo, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
January 8, 2026
Cumulative environmental exposures adversely impact social behaviour and are associated with dysregulation of genes and proteins involved in epigenetic, ribosomal, and immune regulation in male mice
Morgan C Bucknor, Brooke A Keating, Velda X Han, et al.
Cell Reports. Medicine
|
January 20, 2023
Humoral signatures of MOG-antibody-associated disease track with age and disease activity
Marianna Spatola, Omar Chuquisana, Wonyeong Jung, et al.
Human Mutation
|
April 23, 2014
TCIRG1-associated congenital neutropenia
Vahagn Makaryan, Elisabeth A Rosenthal, Audrey Anna Bolyard, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
November 19, 2025
Butyrate modifies epigenetic and immune pathways in peripheral mononuclear cells from children with neurodevelopmental disorders associated with chromatin dysregulation
Jessica P Hayes, Velda X Han, Brooke A Keating, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 17, 2017
Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination
Sudarshini Ramanathan, Shekeeb Mohammad, Esther Tantsis, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
October 24, 2014
Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton
Russell C Dale, Esther M Tantsis, Vera Merheb, et al.
Clinical & Translational Immunology
|
January 11, 2021
Pro-inflammatory dopamine-2 receptor-specific T cells in paediatric movement and psychiatric disorders
Deepti Pilli, Alicia Zou, Ruebena Dawes, et al.
Page
of 89